GRACE: Evaluating Compression Stockings in Patients That Require Extended Duration Pharmacological Thromboprophylaxis

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

8608 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-04-27

Study Completion Date

2027-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Individuals attending the hospital to undergo operations are at risk of developing blood clots in the legs, known as deep vein thrombosis (DVT). A clot in the leg can cause swelling, pain, and other long-term problems. If a clot in the leg breaks off and travels to the lungs, it can cause problems with the lungs' ability to move oxygen from the air into the blood and may be life-threatening. This is known as pulmonary embolism (PE). DVT and PE are known collectively as venous thromboembolism or VTE.

The importance of preventing VTE in surgical patients is widely recognised, with two main strategies used: thinning the blood with regular injections and/or tablets and wearing elastic stockings to help stop blood from sitting in the leg veins where it can clot.

Evidence for using elastic stockings to prevent VTE has recently been challenged. Additionally, there is a lack of evidence for the additional benefit of stockings over and above that of blood thinning medications. If stockings were to reduce VTE over and above blood thinning medication, these benefits need to be weighed against the risks and disadvantages of stockings, including discomfort, restricting blood flow to the leg causing blisters and wounds in addition to the cost. If stockings were found not to reduce the risk of clots, they would no longer need to be used in these patients, thus reducing the disadvantages of stockings, and saving the NHS millions of pounds per year.

Certain types of operations (300,000 per year in the UK) are linked with a particularly high risk of VTE, including cancer surgery, surgery in the abdomen and pelvis, and bone (orthopaedic) surgery. In these cases, patients are offered blood thinning medications both during their hospital stay and for a period after they have left the hospital. Furthermore, these patients are offered stockings to wear while in the hospital.

It is not known if, in patients who receive blood thinning medications both in hospital and after discharge, the addition of wearing stockings whilst in hospital reduces their risk of VTE any further.

The purpose of this study is to investigate if it is worthwhile using stockings, in addition to blood thinning medication, to reduce blood clots after surgery. People enrolled in the study will be those at the highest risk of VTE and require an extended period of medication to reduce the risk of a blood clot.

A computer will randomly choose one of the below treatments by chance to make the trial fair:

A) Extended duration clot-reducing medicine in addition to stockings B) Extended duration clot-reducing medicine alone

The surgery and all the other medical care will continue as normal. Everyone in the study will get an ultrasound scan at 21 - 35 days after their operation to check if they have developed a blood clot. This is an additional scan, not routinely performed in the NHS, to make sure that all blood clots are detected at an early stage. Participants will receive a phone call at 7, 21-35 and 90 days after their treatment to see if they have developed a blood clot or had any problems with the treatment.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Examining the Benefit of Graduated Compression Stockings in the Prevention of vEnous Thromboembolism in Low-risk Surgical Patients

NCT05347550

Venous Thromboembolism

RECRUITING NA

Elastic Compression Stockings and Varicose Veins Recurrence

NCT04231942

Varicose Veins Chronic Venous Insufficiency

ACTIVE_NOT_RECRUITING NA

Intermittent Pneumatic Compression in Surgical Patients at Extremely-high Risk for Venous Thromboembolism

NCT03044574

Venous Thromboembolism Venous Thrombosis

COMPLETED NA

Graduated Compression Stockings (GCS) Pilot Substudy

NCT01234064

Venous Thromboembolism

COMPLETED PHASE3

Compression Aided Management of Edema in Patients With C3 Venous Disease

NCT00766974

Chronic Venous Disease

UNKNOWN PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Research question: Is it beneficial to provide graduated compression stockings (GCS) in addition to extended duration pharmacological thromboprophylaxis (EDPTP) for surgical patients at highest risk of venous thromboembolism (VTE)? Background: Hospital-acquired thrombosis (HAT) is defined as any VTE within 90 days of hospital admission, encompassing both deep vein thrombosis (DVT) and pulmonary embolism (PE). HAT represents a significant cause of preventable mortality, with over 12,000 people dying each year from hospital-associated VTE in the UK, 10-fold higher than the number dying from road traffic accidents.

Previous studies report that the risk of untreated high-risk surgical patients developing HAT is as high as 40-60% in orthopaedic patients and 15-40% in general surgery patients. For these patients at highest risk of VTE, key prevention strategies include extended pharmacological thromboprophylaxis (EDPTP) prescribed beyond hospital discharge and provision of graduated compression stockings (GCS). There is compelling evidence to support the use of pharmacological thromboprophylaxis, however, there is little evidence to support the use of additional GCS alongside causing complications in as many as 5% of patients. The cost of providing GCS equates to a minimum of £31.05 per patient episode, with as many as 270,000 relevant procedures conferring a high-risk of VTE, it could be costing the NHS £8.3 million per annum.

Aims and objectives: The GRACE trial aims to establish whether:-

1. patients undergoing surgical procedures requiring EDPTP benefit from additional GCS to prevent VTE
2. patients receiving GCS experience an increased rate of adverse events

Methods: Assessor-blinded randomised controlled trial with a non-inferiority comparison. 8,608 participants will be randomised in a 1:1 fashion to one of two thromboprophylaxis strategies:

1. EDPTP\* in addition to GCS, or
2. EDPTP alone \*EDPTP includes any anti-thrombotic agent prescribed at a prophylactic dose for prevention of VTE, including low-molecular weight heparin, directly acting oral anticoagulants, or antiplatelet therapy.

Everyone in the study will get an ultrasound scan at 21 - 35 days after their operation to check if they have developed a blood clot. This is an additional scan, not routinely performed in the NHS, to make sure that all blood clots are detected at an early stage. Participants will receive a phone call at 7, 21-35 and 90 days after their treatment to see if they have developed a blood clot or had any problems with the treatment.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Venous Thromboembolism Surgery

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Assessor-blinded randomised controlled trial with a non-inferiority comparison

Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Outcome Assessors

Assessor blinded

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

EDPTP plus GCS

Control - Extended duration pharmacological thromboprophylaxis (EDPTP) and Graduated compression stockings (GCS).

Group Type OTHER

Graduated compression stockings

Intervention Type OTHER

Graduated compression stockings are standard care (control)

EDPTP alone

Intervention - Extended duration pharmacological thromboprophylaxis (EDPTP) alone, no stockings

Group Type OTHER

No Graduated compression stockings

Intervention Type OTHER

No Graduated compression stockings is the intervention

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Graduated compression stockings

Graduated compression stockings are standard care (control)

Intervention Type OTHER

No Graduated compression stockings

No Graduated compression stockings is the intervention

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

TED Stockings No TED Stockings

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adults (≥18 years of age)
* Participants undergoing elective surgery; risk assessed as requiring EDPTP

Exclusion Criteria

* Contraindications to EDPTP or GCS
* Individuals requiring therapeutic anticoagulation e.g., anticoagulation for previous DVT
* Known thrombophilia or thrombogenic disorder

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No